About rRNA methyltransferase 1, mitochondrial
rRNA methyltransferase 1, mitochondrial (MRM1) is a protein
from Homo sapiens identified by UniProt accession
Q6IN84, 353 residues long.
MolForge cross-references it against 0 known binders and
22 disease associations.
Target properties
| Protein name | rRNA methyltransferase 1, mitochondrial |
| UniProt accession | Q6IN84 |
| Gene | MRM1 |
| Organism | Homo sapiens |
| Length | 353 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (22)
Diseases linked to this target (Open Targets).
- macrophage inflammatory protein 1b measurement · score 0.27
- blood protein measurement · score 0.27
- neurodegenerative disease · score 0.26
- body mass index · score 0.23
- mathematical ability · score 0.21
- cystatin C measurement · score 0.17
- creatinine measurement · score 0.11
- high density lipoprotein cholesterol measurement · score 0.06
- physical activity · score 0.06
- self reported educational attainment · score 0.03
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q6IN84-F1 | alphafold | PREDICTED | 78.72 | — |
Amino-acid sequence (353 residues)
MALLSTVRGA TWGRLVTRHF SHAARHGERP GGEELSRLLL DDLVPTSRLE LLFGMTPCLL ALQAARRSVA RLLLQAGKAG LQGKRAELLR MAEARDIPVL RPRRQKLDTM CRYQVHQGVC MEVSPLRPRP WREAGEASPG DDPQQLWLVL DGIQDPRNFG AVLRSAHFLG VDKVITSRRN SCPLTPVVSK SSAGAMEVMD VFSTDDLTGF LQTKAQQGWL VAGTVGCPST EDPQSSEIPI MSCLEFLWER PTLLVLGNEG SGLSQEVQAS CQLLLTILPR RQLPPGLESL NVSVAAGILL HSICSQRKGF PTEGERRQLL QDPQEPSARS EGLSMAQHPG LSSGPEKERQ NEG
Explore rRNA methyltransferase 1, mitochondrial with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets